尽管美国食品药品管理局（FDA）一再拖延，但专家预计多奈单抗将获批用于治疗阿尔茨海默病

{"title":"尽管美国食品药品管理局（FDA）一再拖延，但专家预计多奈单抗将获批用于治疗阿尔茨海默病","authors":"Susan Fitzgerald","doi":"10.1097/01.nt.0001012796.65627.69","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19197,"journal":{"name":"Neurology Today","volume":" 14","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Despite FDA Delays, Experts Anticipate Donanemab Will Be Approved for Alzheimer's Disease\",\"authors\":\"Susan Fitzgerald\",\"doi\":\"10.1097/01.nt.0001012796.65627.69\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":19197,\"journal\":{\"name\":\"Neurology Today\",\"volume\":\" 14\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurology Today\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/01.nt.0001012796.65627.69\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology Today","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.nt.0001012796.65627.69","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}